EyeGene,Inc
Develops gene/cell therapies for age-related diseases and preventive vaccines.
185490 | KO
Overview
Corporate Details
- ISIN(s):
- KR7185490000
- LEI:
- Country:
- South Korea
- Address:
- 경기도 의왕시 양지편2로 13 2층, 의왕시
- Website:
- https://eyegene.co.kr/en/
Description
EyeGene, Inc. is a clinical-stage biopharmaceutical company that researches and develops innovative therapeutics, with a primary focus on gene and cell therapy for age-related diseases. The company's pipeline includes EG-Mirotin, a treatment candidate for non-proliferative diabetic retinopathy and dry age-related macular degeneration. EyeGene is also developing preventive vaccines, such as EG-HPV for cervical cancer, utilizing its proprietary EG-Vac adjuvant system to enhance vaccine efficacy. The company is dedicated to creating transformative treatments by advancing biomedical science.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-04-13 00:00 |
[기재정정]주요사항보고서(유무상증자결정)
|
Korean | 53.0 KB | ||
| 2021-04-12 00:00 |
주요사항보고서(유무상증자결정)
|
Korean | 45.2 KB | ||
| 2021-04-12 00:00 |
주권매매거래정지(무상증자)
|
Korean | 4.7 KB | ||
| 2021-04-12 00:00 |
증권신고서(지분증권)
|
Korean | 1.9 MB | ||
| 2021-04-07 00:00 |
[기재정정]정기주주총회결과
|
Korean | 31.2 KB | ||
| 2021-03-29 00:00 |
전환사채(해외전환사채포함)발행후만기전사채취득
|
Korean | 10.3 KB | ||
| 2021-03-25 00:00 |
정기주주총회결과
|
Korean | 25.8 KB | ||
| 2021-03-17 00:00 |
감사보고서제출
|
Korean | 24.8 KB | ||
| 2021-03-17 00:00 |
[기재정정]감사보고서제출
|
Korean | 28.2 KB | ||
| 2021-03-17 00:00 |
사업보고서 (2020.12)
|
Korean | 1.5 MB | ||
| 2021-03-10 00:00 |
주주총회소집공고
|
Korean | 767.2 KB | ||
| 2021-03-03 00:00 |
주주총회소집결의
|
Korean | 18.4 KB | ||
| 2021-02-24 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 10.6 KB | ||
| 2021-02-16 00:00 |
기타경영사항(특허권취득)(자율공시)(면역반응 조절물질 및 양이온성 리포좀을 포함하는 면역증강용 조성물 및 이의 용도)
|
Korean | 10.0 KB | ||
| 2021-01-22 00:00 |
기타경영사항(자율공시)([국책과제] 백신실용화기술개발사업단, 신변종감염병백신개발플랫폼- 신속 백신 제작 플랫폼 개발 사업 선정)
|
Korean | 9.1 KB |
Automate Your Workflow. Get a real-time feed of all EyeGene,Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for EyeGene,Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for EyeGene,Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
